Cue Biopharma (CUE)

Cue Biopharma (CUE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $117M; returns 1 day -1.2%, 1 week +11.7%, 1 year -20.3%.

Cue Biopharma is a clinical-stage biopharmaceutical company developing a novel class of injectable biologics designed to selectively engage and modulate disease-specific T cells directly within the patient's body. The company's core technology is its proprietary Immuno-STAT™ (Selective Targeting and Alteration of T cells) platform.

Groups CUE belongs to

• Biotechnology
• Recent Reverse Splits
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Immunotherapy
• Biologics
• Oncology
• Autoimmune Diseases
• Healthcare
• R&D

CUE financial model: income statement, cash flow and balance sheet